Denied

No. 19-1451

Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of 9/29/2020.

Reply of petitioner Sanofi-Aventis Deutschland GmbH filed. (Distributed)

Brief of respondent Mylan Pharmaceuticals Inc. in opposition filed.

Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2020.

Motion to extend the time to file a response from August 3, 2020 to August 24, 2020, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due August 3, 2020)

Parties

Sanofi-Aventis Deutschland GmbH, Petitioner, represented by Adam Baker Banks

Mylan, Respondent, represented by Douglas H Carsten

Mylan Pharmaceuticals Inc., Respondent, represented by Steffen Nathanael Johnson

Mylan Pharmaceuticals Inc., Respondent, represented by Richard Lee Torczon Jr.

 
Last updated: November 21, 2024